In summary, this report provides a new paradigm for exploring biomarkers of prostate cancer progression via insights into the differential regulation of AR or TGF-β signaling by PMEPA1-a and PMEPA1-b isoforms, respectively. Here, PMEPA1 is linked to prostate carcinoma.